Forma Life Sciences is a U.S.-based CDMO providing end-to-end formulation development, analytical, clinical manufacturing and commercial manufacturing services for oral solid dosage products. Headquartered in Irvine, California, the company operates two cGMP manufacturing facilities with more than 100,000 square feet of development and manufacturing space, supporting pharmaceutical and biotechnology companies from early clinical development through commercial supply.

Established as an independent company in 2026, Forma builds on nearly three decades of formulation and manufacturing experience inherited from PharmaForm, Formex, BioDuro, Anchen, Par Pharmaceutical and Endo. The company focuses on solving complex formulation and manufacturing challenges through integrated scientific, analytical and manufacturing expertise while maintaining a strong emphasis on quality, scalability and regulatory compliance.

Its capabilities are centred on complex oral solid dosage forms, including modified-release formulations, spray dried dispersions, high-potency compounds and controlled substances. Forma also supports oral biologics, applying formulation technologies designed to improve the oral delivery of peptides, enzymes and other biologic therapies. Its manufacturing platform spans development through commercial production, with facilities capable of producing more than two billion dosage forms annually.

Key Products and Services

• Contract development and manufacturing (CDMO) services
• Formulation development for oral solid dosage products
• Analytical method development and testing
• Clinical manufacturing (preclinical to Phase II)
• Late-stage clinical and commercial manufacturing
• Technology transfer and process scale-up
• Commercial supply and lifecycle manufacturing
• Spray dried dispersion formulation
• Hot melt extrusion (HME)
• Modified-release formulation development
• Oral biologics formulation
• High-potency API handling (up to OHC 3)
• Schedule II–V controlled substance manufacturing
• Regulatory and quality support
• Process optimisation and validation

Forma Life Sciences positions itself as a next-generation CDMO focused on complex oral solid dosage development and manufacturing. Through its integrated scientific expertise, cGMP manufacturing infrastructure and commercial-scale capabilities, the company supports pharmaceutical and biotechnology partners from early development through product commercialisation while helping address formulation, scale-up and manufacturing challenges.